AFT Pharmaceuticals - ASX Listing (AFP)

Location:: Auckland, New Zealand
Market Cap:: $238 million
Sector:: Health Care
Website:: http://www.aftpharm.com/

Share Price & Volume

Latest Open Briefings

22 May 2025
FY2025 Full Year Results Analyst Briefing
21 Nov 2024
FY2025 Half Year Results Analyst Briefing
02 Aug 2024
AFT Pharmaceuticals 2024 Annual General Meeting
23 Nov 2023
FY2024 Half Year Results Analyst Briefing
04 Aug 2023
AFT Pharmaceuticals 2023 Annual General Meeting

Load next 5 items

Latest Market Announcements

07:31 27 Jun
Disclosure of Directors and Senior Managers Relevant Interes
07:30 27 Jun
Notice of Annual Meeting of Shareholders 2025
15:04 24 Jun
Update - Dividend/Distribution - AFP
10:00 24 Jun
Update - Dividend/Distribution - AFP
10:06 26 May
AFT and Hikma extend US Maxigesic Cooperation

Load next 5 items

ASX Announcements delayed by 20 minutes.

You may also be interested in...

View all

Other Open Briefings in the Health Care Sector

22 May 2025
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Full Year Results Analyst Briefing
27 Mar 2025
Healius Limited (HLS)
Healius Investor Day
03 Mar 2025
Pacific Smiles Group Limited (PSQ)
Pacific Smiles Group Half Year Results Briefing
27 Feb 2025
Monash IVF Group Limited (MVF)
Monash IVF Group Limited FY25 Half Year Results announcement
20 Feb 2025
Healius Limited (HLS)
Healius 1H25 Results
21 Nov 2024
AFT Pharmaceuticals - ASX Listing (AFP)
FY2025 Half Year Results Analyst Briefing
23 Sep 2024
Healius Limited (HLS)
Sale of Lumus Imaging
18 Sep 2024
Clarity Pharmaceuticals Ltd (CU6)
Investor Update
28 Aug 2024
Ecofibre Limited (EOF)
EOF FY24 Results
28 Aug 2024
SomnoMed Limited (SOM)
FY24 Results

About Us

Open Briefing is an online investor communication platform that provides ASX listed companies with a dedicated site for hosting, distributing and archiving important market updates and provides investors with a central resource for increasing their understanding of a company's fundamentals and strategic direction. Read more

Stay Informed

Subscribe to receive the latest Open Briefings